Table 5.
Optimal PAPi Group* | ||||
---|---|---|---|---|
Outcomes, n (%) | Total (N = 315) | >3.33 (n = 236) | ≤3.33 (n = 79) | P-value |
The primary outcome: Early RVF after LVAD implantation | 70 (22.2) | 26 (11) | 44 (55.7) | <.001 |
The secondary outcome: Death after LVAD implantation | 41 (13.0) | 26 (11) | 15 (19.0) | .068 |